Leading health officials are once again sounding the alarm of further spread when people gather for the year-end holidays.
“We’re in for a very challenging period,” top infectious disease expert Dr. Anthony Fauci told a virtual summit on Tuesday. Pfizer cleared another hurdle when the U.S. Food and Drug Administration released documents that raised no new red flags over the safety or efficacy of the vaccine it developed with Germany’s BioNTech.
Allergy warning over Pfizer vaccine Britain’s medicine regulator has advised that people with a history of significant allergic reactions do not get Pfizer-BioNTech’s COVID-19 vaccine after two people reported adverse effects on the first day of rollout.
Britain began mass vaccinating its population in a global drive that poses one of the biggest logistical challenges in peacetime history, starting with the elderly and frontline workers.
Merkel pushes for tougher German lockdown Chancellor Angela Merkel threw her weight behind calls for a fuller lockdown in Germany that would include closing shops after Christmas, telling legislators that vaccines alone would not majorly alter the pandemic’s course in the first quarter.
Europe’s largest economy has been in partial lockdown for six weeks, with bars and restaurants closed but shops and schools open. That has stopped the coronavirus’s exponential growth but infection levels remain at a high level.
Rich countries have bought too many vaccines, says Amnesty Rich countries have secured enough coronavirus vaccines to protect their populations nearly three times over by the end of 2021, Amnesty International and other groups said, possibly depriving billions of people in poorer areas.
We need your help to tell these stories. Our news organization wants to capture the full scope of what’s happening and how we got here by drawing on a wide variety of sources.
Are you a government employee or contractor involved in coronavirus testing or the wider public health response? Are you a doctor, nurse or health worker caring for patients? Have you worked on similar outbreaks in the past? Has the disease known as COVID-19 personally affected you or your family? Are you aware of new problems that are about to emerge, such as critical supply shortages?
We need your tips, firsthand accounts, relevant documents or expert knowledge. Please contact us at firstname.lastname@example.org.
We prefer tips from named sources, but if you’d rather remain anonymous, you can submit a confidential news tip. Here’s how.
Posted by ADMIN at 10:48 pm on 12 December 2020HOME